| NGL Fine Chem Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524774 |
NSE Symbol : NGLFINE |
P/E(TTM) : 51.35 |
|
ISIN Demat : INE887E01022 |
Div & Yield% : 0.13 |
EPS(TTM) : 25.57 |
|
Book Value(₹) : 475.67 |
Market Cap(₹Cr) : 811.43 |
Face Value(₹) : 5.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 116.84 | 100.86 | 93.02 | 86.83 | 91.41 | 88.03 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 116.84 | 100.86 | 93.02 | 86.83 | 91.41 | 88.03 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 2.41 | 6.55 | -0.79 | 0.15 | 5.43 | 6.27 |
| Total Income | 119.25 | 107.41 | 92.23 | 86.98 | 96.84 | 94.30 |
| Total Expenditure | 103.17 | 93.04 | 89.11 | 83.28 | 80.79 | 81.72 |
| PBIDT | 16.08 | 14.37 | 3.12 | 3.71 | 16.05 | 12.59 |
| Interest | 1.15 | 1.21 | 0.95 | 0.69 | 0.32 | 0.44 |
| PBDT | 14.92 | 13.16 | 2.17 | 3.02 | 15.73 | 12.14 |
| Depreciation | 4.26 | 3.45 | 2.53 | 2.21 | 2.30 | 2.14 |
| Tax | 3.39 | 0.72 | -0.26 | 1.15 | 2.63 | 1.83 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.63 | 1.35 | 0.42 | -1.12 | 0.76 | 0.35 |
| Reported Profit After Tax | 7.90 | 7.64 | -0.52 | 0.78 | 10.04 | 7.83 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 7.90 | 7.64 | -0.52 | 0.78 | 10.04 | 7.83 |
| EPS (Unit Curr.) | 12.78 | 12.37 | -0.84 | 1.27 | 16.26 | 12.67 |
| EPS (Adj) (Unit Curr.) | 12.78 | 12.37 | -0.84 | 1.27 | 16.26 | 12.67 |
| Calculated EPS (Unit Curr.) | 12.78 | 12.37 | -0.84 | 1.27 | 16.26 | 12.67 |
| Calculated EPS (Adj) (Unit Curr.) | 12.78 | 12.37 | -0.84 | 1.27 | 16.26 | 12.67 |
| Calculated EPS (Ann.) (Unit Curr.) | 51.14 | 49.49 | -3.37 | 5.07 | 65.03 | 50.67 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 51.14 | 49.49 | -3.37 | 5.07 | 65.03 | 50.67 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 |
| Reserve & Surplus | 290.87 | 0.00 | 0.00 | 0.00 | 276.22 | 0.00 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 13.76 | 14.25 | 3.35 | 4.27 | 17.56 | 14.30 |
| PBDTM(%) | 12.77 | 13.05 | 2.33 | 3.48 | 17.21 | 13.79 |
| PATM(%) | 6.76 | 7.57 | -0.56 | 0.90 | 10.98 | 8.89 |